JPMORGAN CHASE & CO - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$72,117,000
+15646.1%
3,017,418
+9508.4%
0.01%
Q4 2020$458,000
+26.2%
31,404
+21.0%
0.00%
Q3 2020$363,000
+0.8%
25,961
+5.9%
0.00%
Q2 2020$360,000
+380.0%
24,518
+34.7%
0.00%
Q1 2020$75,000
-98.2%
18,196
-98.0%
0.00%
-100.0%
Q4 2019$4,274,000
-29.6%
888,590
-11.3%
0.00%0.0%
Q3 2019$6,073,000
-24.7%
1,002,174
-20.9%
0.00%
-50.0%
Q2 2019$8,062,000
-50.7%
1,267,627
-45.0%
0.00%
-33.3%
Q1 2019$16,345,000
-11.0%
2,305,316
-39.0%
0.00%
-25.0%
Q4 2018$18,355,000
-43.4%
3,776,835
-14.5%
0.00%
-33.3%
Q3 2018$32,448,000
+16.2%
4,414,814
+0.8%
0.01%0.0%
Q2 2018$27,935,000
+4.7%
4,378,714
-10.7%
0.01%0.0%
Q1 2018$26,679,000
+34.0%
4,904,257
+2.8%
0.01%
+50.0%
Q4 2017$19,903,000
-51.8%
4,772,753
+8.5%
0.00%
-55.6%
Q3 2017$41,288,000
-14.8%
4,396,940
+7.3%
0.01%
-18.2%
Q2 2017$48,476,000
+6.9%
4,097,767
+15.8%
0.01%
+10.0%
Q1 2017$45,359,000
+10.1%
3,538,138
+5.1%
0.01%0.0%
Q4 2016$41,214,000
+3.1%
3,367,161
-0.6%
0.01%0.0%
Q3 2016$39,976,000
+52.4%
3,387,785
+12.4%
0.01%
+42.9%
Q2 2016$26,225,000
+62.5%
3,014,259
-1.6%
0.01%
+75.0%
Q1 2016$16,138,000
-36.3%
3,062,337
-6.2%
0.00%
-33.3%
Q4 2015$25,339,000
+9.8%
3,265,474
+11.3%
0.01%0.0%
Q3 2015$23,087,000
-33.1%
2,933,532
-23.0%
0.01%
-25.0%
Q2 2015$34,511,000
-26.8%
3,809,211
+4.8%
0.01%
-27.3%
Q1 2015$47,168,000
-5.6%
3,633,840
-1.0%
0.01%0.0%
Q4 2014$49,952,000
+70.7%
3,670,297
+12.5%
0.01%
+57.1%
Q3 2014$29,264,000
-28.9%
3,262,552
+7.3%
0.01%
-30.0%
Q2 2014$41,147,000
+22.3%
3,041,137
-10.1%
0.01%
+11.1%
Q1 2014$33,641,000
-0.8%
3,384,273
+32.6%
0.01%
-10.0%
Q4 2013$33,923,000
+33.7%
2,552,520
+22.1%
0.01%
+25.0%
Q3 2013$25,373,000
+586.5%
2,090,117
+485.2%
0.01%
+700.0%
Q2 2013$3,696,000357,1550.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders